Literature DB >> 15361397

Relationship between disease activity and infection in patients with spondyloarthropathies.

A Martínez1, C Pacheco-Tena, J Vázquez-Mellado, R Burgos-Vargas.   

Abstract

OBJECTIVE: To assess the relationship between disease activity and signs and symptoms of infection in Mexican patients with spondyloarthropathies (SpA).
METHODS: A cross sectional study of 95 non-selected patients with SpA (62 men; mean age 26.4 years), who were examined for signs and symptoms of infection and their association with disease activity. 52 had ankylosing spondylitis (AS), 32 undifferentiated SpA (uSpA), 6 chronic reactive arthritis (ReA), and 5 psoriatic arthritis (PsA). Categorical data were analysed by chi(2) or Fisher's tests.
RESULTS: 53 (56%) patients had infections: 41 (43%) upper respiratory tract (URT), 34 (36%) enteric, and 20 (21%) genitourinary infections. More infections occurred in HLA-B27 positive patients as a whole (39 v 5; p = 0.003) and in uSpA (12 v 2; p = 0.005). In AS and uSpA, infections occurred in approximately 50%. 30/39 (77%) patients with active disease (group A) and 23/56 (41%) (group B) (p = 0.001) had infection. There were more enteric infections in group A (47%; p<0.001) and more URT infections in group B (52%; p = NS). 22/30 (73%) patients attributed disease activity to infection.
CONCLUSION: Enteric, and less commonly, URT infections in Mexican patients with SpA, particularly those who were HLA-B27 positive, seem to have a role in the active phase of AS and uSpA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361397      PMCID: PMC1754767          DOI: 10.1136/ard.2003.011882

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  8 in total

1.  The high prevalence of infections and allergic symptoms in patients with ankylosing spondylitis is associated with clinical symptoms.

Authors:  Jane Zochling; Martin H J Bohl-Bühler; Xenofon Baraliakos; Ernst Feldtkeller; Jürgen Braun
Journal:  Clin Rheumatol       Date:  2005-12-23       Impact factor: 2.980

2.  Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis.

Authors:  N-S Lai; H-C Yu; H-C Chen; C-L Yu; H-B Huang; M-C Lu
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

Review 3.  Undifferentiated spondyloarthritis: a global perspective.

Authors:  Rubén Burgos-Vargas
Journal:  Curr Rheumatol Rep       Date:  2007-10       Impact factor: 4.592

Review 4.  Ankylosing spondylitis is linked to Klebsiella--the evidence.

Authors:  Taha Rashid; Alan Ebringer
Journal:  Clin Rheumatol       Date:  2006-12-21       Impact factor: 3.650

5.  Ankylosing spondylitis risk factors: a systematic literature review.

Authors:  Mark C Hwang; Lauren Ridley; John D Reveille
Journal:  Clin Rheumatol       Date:  2021-03-22       Impact factor: 3.650

Review 6.  A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing Spondylitis.

Authors:  Lianjun Yang; Liping Wang; Xin Wang; Cory J Xian; Hai Lu
Journal:  Int J Mol Sci       Date:  2016-12-17       Impact factor: 5.923

7.  Elevated TRAF4 expression impaired LPS-induced autophagy in mesenchymal stem cells from ankylosing spondylitis patients.

Authors:  Jinteng Li; Peng Wang; Zhongyu Xie; Rui Yang; Yuxi Li; Xiaohua Wu; Hongjun Su; Wen Deng; Shan Wang; Zhenhua Liu; Shuizhong Cen; Yi Ouyang; Yanfeng Wu; Huiyong Shen
Journal:  Exp Mol Med       Date:  2017-06-09       Impact factor: 8.718

Review 8.  Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized Immunotherapies.

Authors:  Joana R Lérias; Georgia Paraschoudi; Eric de Sousa; João Martins; Carolina Condeço; Nuno Figueiredo; Carlos Carvalho; Ernest Dodoo; Mireia Castillo-Martin; Antonio Beltrán; Dário Ligeiro; Martin Rao; Alimuddin Zumla; Markus Maeurer
Journal:  Front Cell Dev Biol       Date:  2020-01-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.